Endogenous antimicrobial peptide LL-37 induces human vasodilatation

British Journal of Anaesthesia

Volumn 100, Issue 6, 2008, Pages 803-809

  Berkestedt, I ^a   Nelson, A ^a   Bodelsson, M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Immune response; Muscle vascular, responses; Receptors, transmembrane

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ENDOTHELIN 1; FORMYLPEPTIDE RECEPTOR LIKE 1; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; POTASSIUM CHLORIDE;

ABDOMINAL SURGERY; ADULT; AGED; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFECT; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SMOOTH MUSCLE; VASODILATATION;

EID: 44649135256     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen074     Document Type: Conference Paper

References (39)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95
3. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003; 254: 197-215
4. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63: 1291-7
5. Cowland JB, Johnsen AH, Borregaard N. hCAP-18, a cathelin/pro-bactenecin- like protein of human neutrophil specific granules. FEBS Lett 1995; 368: 173-6
6. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995; 92: 195-9
7. Sørensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97: 3951-9
8. Larrick JW, Hirata M, Zhong J, Wright SC. Anti-microbial activity of human CAP18 peptides. Immunotechnology 1995; 1: 65-72
9. Ciornei CD, Egesten A, Bodelsson M. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Acta Anaesthesiol Scand 2003; 47: 213-20
10. Agerberth B, Charo J, Werr J, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 3086-93
11. De Y, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192: 1069-74
12. Murphy PM, Ozcelik T, Kenney RT, Tiffany HL, McDermott D, Francke U. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem 1992; 267: 7637-43
13. Brink C, Dahlen SE, Drazen J, et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 2003; 55: 195-227
14. Chiang N, Serhan CN, Dahlen SE, et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 2006; 58: 463-87
15. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002; 23: 541-8
16. Le Y, Gong W, Li B, et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 1999; 163: 6777-84
17. Bae YS, Lee HY, Jo EJ, et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 2004; 173: 607-14
18. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111: 1665-72
19. Takano T, Clish CB, Gronert K, Petasis N, Serhan CN. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Invest 1998; 101: 819-26
20. Wallerstedt SM, Bodelsson M. Endothelium-dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hyperpolarization. Br J Pharmacol 1997; 120: 25-30
21. Riezebos J, Watts IS, Vallance PJ. Endothelin receptors mediating functional responses in human small arteries and veins. Br J Pharmacol 1994; 111: 609-15
22. Thorlacius K, Bodelsson M. Sevoflurane promotes endothelium-dependent smooth muscle relaxation in isolated human omental arteries and veins. Anesth Analg 2004; 99: 423-8
23. Wallerstedt SM, Tornebrandt K, Bodelsson M. Relaxant effects of propofol on human omental arteries and veins. Br J Anaesth 1998; 80: 655-9
24. Bodelsson M, Arneklo-Nobin B, Törnebrandt K. Cooling augments contractile response to 5-hydroxytryptamine via an endothelium-dependent mechanism. Blood Vessels 1989; 26: 347-59
25. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol 1992; 445: 355-67
26. Ammendola R, Russo L, De Felice C, Esposito F, Russo T, Cimino F. Low-affinity receptor-mediated induction of superoxide by N-formyl-methionyl- leucyl-phenylalanine and WKYMVm in IMR90 human fibroblasts. Free Radic Biol Med 2004; 36: 189-200
27. Bodelsson G, Sandström K, Wallerstedt SM, Hidestål J, Törnebrandt K, Bodelsson M. Effects of propofol on substance P-induced relaxation in isolated human omental arteries and veins. Eur J Anaesthesiol 2000; 17: 720-8
28. Wallerstedt SM, Bodelsson M. Effect of propofol on isolated human omental arteries and veins. Br J Anaesth 1997; 78: 296-300
29. Thorlacius K, Zhoujun C, Bodelsson M. Effects of sevoflurane on sympathetic neurotransmission in human omental arteries and veins. Br J Anaesth 2003; 90: 766-73
30. Sørensen O, Cowland JB, Askaa J, Borregaard N. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 1997; 206: 53-9
31. Tarsoly P, Bogar L, Jakso P. Comparison of the flowcytometric characteristics of polymorphonuclear leucocytes in septic patients and healthy volunteers (AIC120). Br J Anaesth 2002; 89: 18
32. Joyce DE, Nelson DR, Grinnell BW. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med 2004; 32: S280-6
33. Rimele TJ, Sturm RJ, Adams LM, et al. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988; 245: 102-11
34. Gonzales J, Mehta JL, Lawson DL, Nichols WW, Nicolini FA. Variable effects of human and canine polymorphonuclear leucocytes on vascular smooth muscle tone. Cardiovasc Res 1992; 26: 751-6
35. Kerr SW, Yu R, Stearns CD, Haynes NA, Winquist RJ. Characterization of the polymorphonuclear leukocyte-induced vasoconstriction in isolated human umbilical veins. J Pharmacol Exp Ther 1998; 287: 640-7
36. Steen S, Skärby TV, Norgren L, Andersson KE. Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated human omental arteries and veins. Acta Physiol Scand 1984; 120: 109-16
37. Törnebrandt K, Nobin A, Owman C. Pharmacological characterization of alpha-adrenergic receptor subtypes mediating contraction in human mesenteric arteries and veins. Blood Vessels 1985; 22: 179-95
38. Nourshargh S, Marelli-Berg FM. Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol 2005; 26: 157-65
39. Eastwood JR, Warren A, Mahajan RP, Girling KJ. Effects of plasma from septic patients on the vascular reactivity of omental blood vessels isolated from patients undergoing routine abdominal surgery. Br J Anaesth 2002; 88: 319-20